News & Publications
REPLICATe IN THE NEWS
Explore recent company announcements, stories about our science, and media coverage.
12.04.25
Press Releases
Replicate Bioscience and Instituto Butantan Enter Collaborative Agreement to Develop and Commercialize Replicate’s Self-Replicating RNA (srRNA) Rabies Vaccine in Latin America
09.24.25
Press Releases
Replicate Bioscience Announces Publication of Promising New Phase 1 Durability Data for Its srRNA Vaccine Candidate RBI-4000
08.28.25
Press Releases
Replicate Bioscience Announces Partnership with Novo Nordisk to Unlock Self-Replicating RNA Therapies for Obesity and Diabetes
02.07.25
Press Releases
Replicate Bioscience Announces Publication of First-in-Human Data for Its Optimized srRNA Rabies Vaccine in Nature Communications
08.21.24
Press Releases
Replicate Bioscience to Participate in Upcoming Investor and Scientific Conferences
05.11.24
Press Releases
Replicate Bioscience Presents Positive Data from Phase 1 Trial and Preclinical Data with Novel Self-Replicating RNA at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
04.22.24
Press Releases
Replicate Bioscience Announces Oral Presentations at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
03.01.24
Press Releases
Replicate Bioscience to Participate in Upcoming Investor and Scientific Conferences